AXON NEUROSCIENCES
AXON NEUROSCIENCES
Industry:
CRM Health Care Information Technology
Founded:
1999-04-06
Address:
Larnaca, Larnaca, Cyprus
Country:
Cyprus
Website Url:
http://www.axon-neuroscience.eu
Total Employee:
101+
Status:
Active
Contact:
866.658.3979
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default HSTS DMARC ReCAPTCHA Apache Pound Sterling ReCAPTCHA V2
Similar Organizations
Cellexus
Revolutionary single use bioreactor systems
Current Employees Featured
Founder
Official Site Inspections
http://www.axon-neuroscience.eu Semrush global rank: 16.34 M Semrush visits lastest month: 38
- Host name: totoro.rainside.sk
- IP address: 212.89.224.72
- Location: Bratislava Slovakia
- Latitude: 48.15
- Longitude: 17.1078
- Timezone: Europe/Bratislava
- Postal: 851 03
More informations about "Axon Neurosciences"
AXON Neuroscience SE
AXON Neuroscience SE is a biotech company dedicated to the development of disease modifying immunotherapy and early diagnostics for Alzheimer's disease. ... [email protected]. Partners contact +421 2 2092 1620 โฆSee details»
Axon Neurosciences - Crunchbase Company Profile & Funding
Headquarters Regions Europe, Middle East, and Africa (EMEA), European Union (EU), Middle East; Founded Date Apr 6, 1999; Founders Michal Novak; Operating Status Active; Company โฆSee details»
AXON Neuroscience SE
Tel.: +421 2 2092 1620 | E-Mail: of๏ฌ[email protected] | Web: www.axon-neuroscience.eu. History of AXON Neuroscience 1988 Michal Novak, while working with three โฆSee details»
AXON NEUROSCIENCE SE Company Profile - Dun & Bradstreet
Axon neuroscience se. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / cyprus / larnaca / axon โฆSee details»
Axon Neuroscience - VentureRadar
Axon Neuroscience is a clinical-stage biotech company developing disease-modifying immunotherapeutics for Alzheimer's disease and Frontotemporal lobar degeneration. Ground โฆSee details»
AXON Neuroscience - LinkedIn
AXON Neuroscience is a clinical-stage biotech company founded in 1999 with a specialized team of researchers focused exclusively on tau immunotherapies and tau diagnostic platforms. โฆSee details»
AXON Neuroscience Company Profile - Office Locations ... - Craft
AXON Neuroscience is a clinical stage biotech company focused on tau immunotherapies and tau diagnostic platforms. It is engaged in the development of disease-modifying therapies for the โฆSee details»
Orphanet: AXON NEUROSCIENCE SE
AXON NEUROSCIENCE SE. 4 Arch. Makariou & Kalogreon. 6016 LARNACA . CYPRUS. Phone 1: +357 2425 2636 Contact email: [email protected]. Institution's website โฆSee details»
Axon Neuroscience Company Profile | Management and โฆ
Axon Neuroscience is an industry leading, clinical stage biotech company and an innovator in the development of peptide vaccines against so-far incurable brain diseases. The company was โฆSee details»
AXON Neuroscience Overview | SignalHire Company Profile
AXON Neuroscience is a private company that has been in the industry for 24 years. The company currently specializes in the Biotechnology, Biotechnology areas. ... Organization โฆSee details»
Axon Neuroscience - PitchBook
Axon Neuroscience General Information Description. Developer of disease-modifying immunotherapeutics designed to treat Alzheimer's disease and other tauopathies. The company develops tau-based treatments that halt the โฆSee details»
AXON Neuroscience SE
AXON Neuroscience SE In 1988, Michal Novak, Claude Wischik, Cesar Milstein and Aron Klug from the Laboratory of Molecular Biology, MRC, Cambridge, UK, discov - ... European โฆSee details»
Axon Neuroscience - Products, Competitors, Financials, Employees ...
Axon Neuroscience is a clinical-stage biotech company focused on developing tau-based treatments for Alzheimer's disease and other tauopathies. The company's main offerings โฆSee details»
AXON Neuroscience SE - Drug pipelines, Patents, Clinical trials
Cyprus-based AXON Neuroscience is in Phase II clinical development with AADvac1, which instructs the patient's immune system to generate specific antibodies targeting tau. In June, โฆSee details»
Axon-Neuroscience - VentureRadar
AXONโs unique proprietary disease models allow rapid identification and validation of new disease targets and biomarkers. The company is a leader in understanding the molecular aspects of โฆSee details»
Axon Neuroscience - Overview, News & Similar companies
View Axon Neuroscience (www.axon-neuroscience.eu) location in Slovakia , revenue, industry and description. Find related and similar companies as well as employees by title and much โฆSee details»
AXON Neuroscience SE: Axon Neuroscience to Present at 2021 โฆ
Jun 10, 2021 About Axon Neuroscience. Axon Neuroscience was founded in 1999 by immunologist Professor Michal Novak. In 1988, while working at Laboratory of Molecular โฆSee details»
AXON Neuroscience - Company Profile & Staff Directory
AXON Neuroscience is a clinical-stage biotech company founded in 1999 with a specialized team of researchers focused exclusively on tau immunotherapies and tau diagnostic platforms. โฆSee details»
AXON Neuroscience SE (AXON Neuroscience SE) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ โฆ
This study is a pilot trial evaluating the safety and immunogenicity of AADvac1 in patients with the non-fluent variant of Primary Progressive Aphasia. 50% of participants will receive the 40 µg โฆSee details»
Theory of axo-axonic inhibition | PLOS Computational Biology
4 days ago Introduction. In most vertebrate neurons, action potentials (APs) initiate in a small axonal structure near the soma, the axon initial segment (AIS) [1,2].In principal cells of the โฆSee details»